vs
M&T Bank（MTB）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
M&T Bank的季度营收约是瑞思迈的1.7倍（$2.5B vs $1.4B），M&T Bank净利率更高（30.7% vs 27.6%，领先3.1%），瑞思迈同比增速更快（11.0% vs 3.8%），过去两年瑞思迈的营收复合增速更高（9.0% vs 4.6%）
M&T银行是总部位于美国纽约州布法罗的银行控股企业，业务覆盖美国东部从缅因州到弗吉尼亚州的12个州及华盛顿特区，运营超过950家线下网点。其控股主体1998年5月前名为第一帝国州公司，之后更为现名。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
MTB vs RMD — 直观对比
营收规模更大
MTB
是对方的1.7倍
$1.4B
营收增速更快
RMD
高出7.2%
3.8%
净利率更高
MTB
高出3.1%
27.6%
两年增速更快
RMD
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.5B | $1.4B |
| 净利润 | $759.0M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 39.2% | 34.6% |
| 净利率 | 30.7% | 27.6% |
| 营收同比 | 3.8% | 11.0% |
| 净利润同比 | 11.5% | 13.9% |
| 每股收益（稀释后） | $4.62 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MTBRMD
| Q4 25 | $2.5B | $1.4B | ||
| Q3 25 | $2.5B | $1.3B | ||
| Q2 25 | $2.4B | $1.3B | ||
| Q1 25 | $2.3B | $1.3B | ||
| Q4 24 | $2.4B | $1.3B | ||
| Q3 24 | $2.3B | $1.2B | ||
| Q2 24 | $2.3B | $1.2B | ||
| Q1 24 | $2.3B | $1.2B |
净利润MTBRMD
| Q4 25 | $759.0M | $392.6M | ||
| Q3 25 | $792.0M | $348.5M | ||
| Q2 25 | $716.0M | $379.7M | ||
| Q1 25 | $584.0M | $365.0M | ||
| Q4 24 | $681.0M | $344.6M | ||
| Q3 24 | $721.0M | $311.4M | ||
| Q2 24 | $655.0M | $292.2M | ||
| Q1 24 | $531.0M | $300.5M |
毛利率MTBRMD
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% | ||
| Q1 24 | — | 57.9% |
营业利润率MTBRMD
| Q4 25 | 39.2% | 34.6% | ||
| Q3 25 | 40.8% | 33.4% | ||
| Q2 25 | 39.0% | 33.7% | ||
| Q1 25 | 33.0% | 33.0% | ||
| Q4 24 | 37.0% | 32.5% | ||
| Q3 24 | 39.0% | 31.6% | ||
| Q2 24 | 37.1% | 31.2% | ||
| Q1 24 | 29.4% | 31.3% |
净利率MTBRMD
| Q4 25 | 30.7% | 27.6% | ||
| Q3 25 | 31.5% | 26.1% | ||
| Q2 25 | 29.9% | 28.2% | ||
| Q1 25 | 25.3% | 28.3% | ||
| Q4 24 | 28.6% | 26.9% | ||
| Q3 24 | 30.9% | 25.4% | ||
| Q2 24 | 28.5% | 23.9% | ||
| Q1 24 | 23.5% | 25.1% |
每股收益（稀释后）MTBRMD
| Q4 25 | $4.62 | $2.68 | ||
| Q3 25 | $4.82 | $2.37 | ||
| Q2 25 | $4.24 | $2.58 | ||
| Q1 25 | $3.32 | $2.48 | ||
| Q4 24 | $3.87 | $2.34 | ||
| Q3 24 | $4.02 | $2.11 | ||
| Q2 24 | $3.73 | $1.97 | ||
| Q1 24 | $3.02 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.4B |
| 总债务越低越好 | $10.9B | $403.9M |
| 股东权益账面价值 | $29.2B | $6.3B |
| 总资产 | $213.5B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.37× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资MTBRMD
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $932.7M | ||
| Q4 24 | — | $521.9M | ||
| Q3 24 | — | $426.4M | ||
| Q2 24 | — | $238.4M | ||
| Q1 24 | — | $237.9M |
总债务MTBRMD
| Q4 25 | $10.9B | $403.9M | ||
| Q3 25 | $12.9B | $408.7M | ||
| Q2 25 | $12.4B | $658.4M | ||
| Q1 25 | $10.5B | $663.1M | ||
| Q4 24 | $12.6B | $662.9M | ||
| Q3 24 | $11.6B | $667.6M | ||
| Q2 24 | $11.3B | $697.3M | ||
| Q1 24 | $11.4B | $997.0M |
股东权益MTBRMD
| Q4 25 | $29.2B | $6.3B | ||
| Q3 25 | $28.7B | $6.1B | ||
| Q2 25 | $28.5B | $6.0B | ||
| Q1 25 | $29.0B | $5.5B | ||
| Q4 24 | $29.0B | $5.3B | ||
| Q3 24 | $28.9B | $5.2B | ||
| Q2 24 | $28.4B | $4.9B | ||
| Q1 24 | $27.2B | $4.6B |
总资产MTBRMD
| Q4 25 | $213.5B | $8.5B | ||
| Q3 25 | $211.3B | $8.3B | ||
| Q2 25 | $211.6B | $8.2B | ||
| Q1 25 | $210.3B | $7.6B | ||
| Q4 24 | $208.1B | $7.1B | ||
| Q3 24 | $211.8B | $7.2B | ||
| Q2 24 | $208.9B | $6.9B | ||
| Q1 24 | $215.1B | $6.8B |
负债/权益比MTBRMD
| Q4 25 | 0.37× | 0.06× | ||
| Q3 25 | 0.45× | 0.07× | ||
| Q2 25 | 0.43× | 0.11× | ||
| Q1 25 | 0.36× | 0.12× | ||
| Q4 24 | 0.43× | 0.13× | ||
| Q3 24 | 0.40× | 0.13× | ||
| Q2 24 | 0.40× | 0.14× | ||
| Q1 24 | 0.42× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0B | $339.7M |
| 自由现金流经营现金流 - 资本支出 | — | $311.2M |
| 自由现金流率自由现金流/营收 | — | 21.9% |
| 资本支出强度资本支出/营收 | — | 2.0% |
| 现金转化率经营现金流/净利润 | 3.96× | 0.87× |
| 过去12个月自由现金流最近4个季度 | — | $1.8B |
8季度趋势，按日历期对齐
经营现金流MTBRMD
| Q4 25 | $3.0B | $339.7M | ||
| Q3 25 | $1.0B | $457.3M | ||
| Q2 25 | $844.0M | $538.8M | ||
| Q1 25 | $635.0M | $578.7M | ||
| Q4 24 | $3.6B | $308.6M | ||
| Q3 24 | $-28.0M | $325.5M | ||
| Q2 24 | $1.4B | $440.1M | ||
| Q1 24 | $608.0M | $402.0M |
自由现金流MTBRMD
| Q4 25 | — | $311.2M | ||
| Q3 25 | — | $414.4M | ||
| Q2 25 | — | $508.2M | ||
| Q1 25 | — | $557.9M | ||
| Q4 24 | — | $288.0M | ||
| Q3 24 | — | $307.7M | ||
| Q2 24 | — | $415.2M | ||
| Q1 24 | — | $380.8M |
自由现金流率MTBRMD
| Q4 25 | — | 21.9% | ||
| Q3 25 | — | 31.0% | ||
| Q2 25 | — | 37.7% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | — | 25.1% | ||
| Q2 24 | — | 33.9% | ||
| Q1 24 | — | 31.8% |
资本支出强度MTBRMD
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 1.8% |
现金转化率MTBRMD
| Q4 25 | 3.96× | 0.87× | ||
| Q3 25 | 1.26× | 1.31× | ||
| Q2 25 | 1.18× | 1.42× | ||
| Q1 25 | 1.09× | 1.59× | ||
| Q4 24 | 5.30× | 0.90× | ||
| Q3 24 | -0.04× | 1.05× | ||
| Q2 24 | 2.07× | 1.51× | ||
| Q1 24 | 1.15× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MTB
暂无分部数据
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
